1 Year Topical Min 12.5% + Fin 0.5%
    10/15/2025

    From the encyclopedia
    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💧 Minoxidil (topical) 12.5% nightly 1 year
    💧 Finasteride (topical) 0.5% nightly 1 year
    💧 dermal roller (topical) 0.5mm monthly
    the tone is 😀 positive with noticeable hair improvement results.

    Other terms

    A 45-year-old male used topical Minoxidil 12.5% and Finasteride 0.5% nightly for a year, with noticeable hair improvement and no side effects. He also used a dermal roller monthly and continued using creatine, attributing his hair's healthier appearance to the treatment.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Microneedling for the Treatment of Hair Loss

      research Microneedling for the treatment of hair loss?

      58 citations , December 2017 in “Journal of The European Academy of Dermatology and Venereology”
      This review highlights that microneedling shows some promise for improving hair growth in alopecia, particularly when used with other treatments, though more research is needed to establish its efficacy and protocols.
      Treatments for Androgenetic Alopecia and Alopecia Areata

      research Treatments for Androgenetic Alopecia and Alopecia Areata

      72 citations , January 2001 in “Drugs”
      This review discusses current and emerging drug therapies for treating androgenetic alopecia and alopecia areata, and reports no clinical results; it highlights a need for improved and novel treatments.
      A Decade of Progress in Androgenetic Alopecia Management: Emerging Therapies and Multimodal Strategies

      research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies

      December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology”
      This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
      Androgenetic Alopecia: An Update Of Treatment Options

      research Androgenetic Alopecia: An Update of Treatment Options

      110 citations , August 2016 in “Drugs”
      Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.